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CANCER AMONG ARAB AMERICANS IN THE METROPOLITAN DETROIT AREA
Detroit is home to one of thp largest populations of Ar,\I,';mcricans outside' of the Middle
Last, yet litLie is known about the Cdncer distribution in this ethnic group. The authors of
this study created an Arab/Chaldean surnamc
list and matched it with the Detroit SEER Registry to identify cancer cases of probahle Arabic
descent. We then determined proport ional incidence ratius (PIR) for specific cancer sites
among metropolitan Detroit Arab Americans
as compared to non-Arab Whites, and contrasted the results with Middle Eastern data.
Arab/Chalded n men had greater proportions of
!eukemia (2l)'}oi, multiple mYl·l()ma (46%), liver
(64%), kidney (33%), and urinary bladder
1.26%) cancers. Arah/Chaldean women had
greater proportions of leukemia (23%), thyroid
(57?o), and brain (35%) cancers as compared
with non-!\r,',b White men ,~1I1d women. The
cancers with significantly increased PIRs in the
Detroit Arab/Chaldean population also are frequently diagnosed in Middle Eastern countries.
(Ethn Dis. 2004;14:141-146)
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INTRODUCTION
Arab Americans constitute one of
the fastest growing immigrant groups in
American metropolitan areas, '.' yet little
is known regarding cancer incidence
and mortality in this population. Studies of migrant Middle Easterners have
been performed in Australia,3 where
higher rates of liver and bladder cancers
were reported in men, stomach and gallbladder cancers in women, and thyroid
cancers in both sexes. Migrant studies
are difficult to perform in this country
because denominator data are not available from the US Census Bureau. Persons of Arab descent do not have a separate racial! ethnic classification; rather,
they are grouped with '\X1hite' on US
Census forms.
At least 250,000 Arab-Americans
and Chaldeans (Iraqi Christians) are estimated to live within metropolitan Detroit (Macomb, Oakland, and Wayne
counties), representing one of the largest
concentrations of immigrant Arabs in
the United States.' The US Census
2000 estimates the number of MuslimOrigin persons in metropolitan Detroit
at 124,585, representing 2. So;.) of the
total population, 4 Undercounting, historically a problem among minority
populations,5 may account for the discrepant estimates. This area is also home
to the Metropolitan Detroit Cancer Surveillance System (MDCSS), a founding
member of the National Cancer Institute's Surveillance, Epidemiology, and
End Results (SEER) Program and a rich
resource of cancer incidence information, Unfortunately, the SEER registry,
which is dependent upon medical chart
review for demographic information,
lacks complete data on Arab descent.
Therefore, cancer incidence patterns are
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poorly defined among this growing ethnic group in metropolitan Detroit.
In this study, we developed an Arahl
Chaldean surname index to identify
cancer cases of probable Arab/Chaldean
descent in the M DCSS and to dctermine proportional incidence ratios
(PIR) for specific cancer sites among
metropolitan Detroit Arab/Chaldeans as
compared to non-Arab Whites. These
results were also compared with cancer
data available from Middle Eastern and
North African countries.

METHODS
Determining the proportional incidence of specific cancer sites for metropolitan Detroit Arab/Chaldeans was a
3-step process. The first step was the
creation of an Arab/Chaldean surname
list. The second step involved matching
this list with the MDCSS Registry to
identify cases of probable Arab/Chaldean descent. For some names, it was also
necessary to supplement the surname
using first names drawn fi'om a second
list created by the research team. The
final step was to determine proportional
incidence ratios. The study was reviewed and approved by the Wayne
State University Institutional Review
Board.

Collection of Arab/Chaldean
Surnames
Arab/Chaldean surnames were derived from the following sources:
Michigan Department of Community
Health birth and death records,
which list birthplace of the decedent
or ancestry of the infant. The countries identified as Middle Eastern/
North Mrican included: Algeria, Bah-
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Studies of migrant Middle
Easterners have been
performed in A ustralia, 3
where higher rates of liver
and bladder cancers were
reported in men, stomach
and gallbladder cancers in
women, and thyroid cancers
in both sexes.

rain, Djibouti, Egypt, Ethiopia, the
Gaza Strip, Iraq, Jordan, Kuwait,
Lebanon, Libya, Morocco, North Africa, Oman, Palestine, Qatar, Saudi
Arabia, Somalia, Sudan, Syria, Tunisia, United Arab Emirates, Yemen,
and the Western Sahara.
MDCSS. Surnames from records that
included a birthplace from the list
above were included in the surname
list.
Arab/Chaldean community outreach
groups and professional groups such
as the Arab Community Center for
Economic and Social Services (ACCESS), Arab-American and Chaldean
Council (ACC), National ArabAmerican Medical Association, the
Chaldean Federation, and churches
and mosques assisted us by supplying
Arab/Chaldean surnames.
Two Arab-speaking research assistants
searched metropolitan Detroit telephone directories for Arab and Chaldean surnames.
First names were collected from the last
2 sources named above, as well as an
Internet listing of baby names. 6
Surnames that recurred most frequently were considered as a proxy for
the most common Arab/Chaldean surnames. The total number of non-unique
surnames gathered from all sources was
91,000, which was reduced to 14,761
142

unique names. The first draft was reviewed and edited by authors (AK and
HF), eliminating many non-Arab/Chaldean names that had arisen from the
Department of Community Health's vital statistics. A consensus was reached
regarding those names that should be
discarded. Surnames that could potentially identify both Arab/Chaldean and
non-Arab/Chaldean persons were kept
as a separate file.
Following the first review of the surname list, a "soundex" match using the
first 3 letters of the edited surname list
was performed with the SEER database
in order to capture additional names
with similar beginnings and alternative
spellings. At the same time, the consultants agreed on several name endings
that could be used to systematically delete non-Arab/Chaldean surnames. Examples of such endings selected were
-wich, -ian, -ski, and -berg. The resulting list, after additions and deletions,
was again reviewed and edited by several
of the authors (AK, HF, WS). The final
master Arab/Chaldean surname list contained 9,225 unique names.
The first name list also underwent a
revision and editing process by AK. The
first name list was used to improve the
probability of identifying Arab/Chaldean cases with surnames common to
both Arab/Chaldeans and non-ArabI
Chaldeans (eg, George, Michael, and Simon). For those surnames that might
identify non-Arab/Chaldeans (equivocal
surnames), a match on both first and
last name was required to be included
in the proportional incidence analysis.
For female cases, the maiden name
listed in MDCSS was the first choice for
matching. If maiden name was not present in the case file, the usual surname
matching criteria were applied.

Quality Control
Several quality control measures
were used to ensure that the surname
list identified as many Arab/Chaldeans
as possible with a minimum number of
false positives. Three different telephone
Ethnicity & Disease, Volume 14, Winter 2004

validation methods were used to estimate the accuracy of the list, using the
6 metropolitan Detroit directories. The
standard procedure for each telephone
quality control check was:
A telephone call was placed to a residence with a telephone number for a
given surname on the list.
The person who answered was asked
whether he or she had that last name;
if not, the caller asked to speak to
someone with that surname.
The respondent was then asked if he or
she considered him/herself to be of
Arab ancestry. The caller spoke in Arabic if the respondent did not understand English.
The first quality control measure
was performed using all surnames obtained from non-state sources (approximately 20,000 non-unique names). To
approximate a 2.5% sample, a telephone
number from a metropolitan Detroit
telephone directory was obtained for every 40th surname on the alpha-ordered
list. Of the 380 households that were
contacted, 340 respondents (89.5%)
identified themselves as Arab/Chaldean.
The second quality control method
used a surname list ordered by frequency of names. Equivocal surnames were
included. Three telephone directories
representing areas with sparse Arabi
Chaldean populations were the source
for telephone numbers. Households
with the 50 most frequent names were
contacted. Forty-three of the 50 names
were found in at least one of the directories, and 29 of the names were contained in all 3 directories. Of the fortythree names found at least once, 42
(97.7%) considered themselves to be of
Arab/Chaldean descent.
For the third quality control step, a
list of approximately 1% of the surnames from all reportable cases, independent of ethnicity, in the MDCSS
was obtained. This list was checked
against the Arab/Chaldean master surname list for overlap. The 5 overlapping
surnames on both lists were not con-
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tacted. Households with the remaining
143 surnames were contacted, using the
3 telephone directories that cover the
most densely populated Arab/Chaldean
areas. Of the 143 households contacted,
143 (100%) identified themselves as
A calculation was also performed to
determine if the number of MDCSS
cases identified by the surname match
was reasonable. The calculation was
made with the assumption that ArabI
Chaldean age-specific cancer incidence
rates are similar to those of Whites.
White age-specific cancer incidence
rates were used to calculate a theoretical
age-specific Arab/Chaldean population.
The resulting numbers closely matched
estimates of the metropolitan Detroit
Arab population made by another independent group. I Further verification
of the matched MDCSS case population, was conducted by comparing the
theoretical population calculated, as described above, with 1990 US Census information on the proportion of Arabicspeaking persons using metropolitan
Detroit census tracts? (Figure 1). The
theoretical age-specific Arab/Chaldean
population was similar to the 1990 agespecific population of census tracts with
greater than 30% of persons who speak
Arabic at home.

dj=number of Arab/Chaldean site-specific cases for
age group j
tj=total number of ArabI
Chaldean cases for age
group j
d*j=number of non-Arab
White site-specific cases
for age group j
t*j=total number of nonArab White cases for age
group j

Statistical Analysis
SAS (Statistical Analysis System)@)
was used to calculate age-adjusted proportional incidence ratios (PIR) and
95% confidence intervals (CI). The cancer sites that are routinely reported by
SEER in their annual Cancer Statistics
Review are included here. If there were
fewer than 10 Arab/Chaldean cases for
a particular cancer site, a PIR was not
calculated. Although the MDCSS contains separate data for colon, rectal, and
rectosigmoid junction cancers, the 3
cancer sites were aggregated into a single
category of colorectal cancer. Similarly,
oral cavity and pharynx is an aggregation of cancers of the lip, tongue, salivary gland, mouth floor, gum, nasopharynx, oropharynx, hypopharynx,
and tonsil. The specific cancer sites were
stratified by sex and age «40 years,
40-49,50-59,60-69, and 70 years and
older). These age-stratifications were
used to determine the age-adjusted
PIRs.
Age-adjusted cancer site-specific
PIRs were calculated by the formula below. s In general, the PIR is the observed
number of Arab/Chaldean cases divided
by the number of Arab/Chaldean cases
expected if the Arab/Chaldean population had the same proportion of cancer
as that of the non-Arab White populaEthnicity &- Disease, Volume 14, Winter 2004

RESULTS
The total number of matches of the
surname list and the SEER database for
the years 1973-2002 was 7006; 3475
male and 3531 female. Among men and
women combined, Arab/Chaldeans had
63% greater than expected proportions
of liver cancer, 44% greater thyroid,
29% greater leukemia, 28% greater
Hodgkin's, 26% greater brain, 25%
greater kidney, and 24% greater urinary
bladder cancers than non-Arab Whites
(Table 1). Non-Arab Whites, however,
experienced 35% more skin melanoma,
27% more esophagus, and 20% more
oral cavity cancers than Arab/Chaldeans.
When stratified by sex, the cancer
sites with a greater PIR for Arab/Chaldean men were liver (64%), multiple
myeloma (46%), kidney (33%), leukemia (29%), and urinary bladder (26%).
Sites with a greater PIR for non-Arab
White men were melanoma (45%), testis (36%), esophagus (36%), and oral
cavity and pharynx (25%).
The proportions of thyroid, brain,
and leukemia cancers were 57%, 35%,
and 23% greater, respectively, for ArabI
Chaldean women than non-Arab White
women. Skin melanoma was again
143
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Table 1. Age-Adjusted Proportional Incidence Ratios (PIRs) for Arab/Chaldeans in
the Detroit metropolitan area, 1973-2002

Cancer Site
Male and females
Oral cavity and pharynx
Esophagus
Stomach
Colorectal
Liver
Gall bladder
Pancreas
Larynx
Lung/bronchus
Skin melanoma
Urinary bladder
Kidney
Brain and other nervous system
Thyroid
Hodgkin's
Non-Hodgkin's
Multiple myeloma
Leukemia

Number of
Cases
Observed

Number of
Cases
Expected

PIR (95% Confidence
Interval)

DISCUSSION
148
43
151
784
63
27
154
86
962
170
407
199
140
147
81
253
84
261

185.5
59.3
129.3
830.6
38.6
21.5
154.4
89.1
1017.3
261.0
328.5
159.6
111.2
102.2
63.4
237.9
68.0
201.9

99
30
96
443
45
83
71
632
83
862
40
330
141
77
35
48
135
55
161

131.7
46.9
86.6
463.2
27.4
83.8
77.0
679.3
152.2
844.4
62.4
262.3
105.8
68.0
29.1
40.0
136.6
37.7
125.1

49
13
55
341
18
18
71
15
330
87
1086
506
214
138
77
58
63
112
33
118
29
100

53.3
14.3
44.8
368.1
12.2
14.2
70.3
15.9
355.2
114.1
1044.1
597.8
228.0
133.8
77.9
56.8
46.7
71.5
26.9
104.4
30.2
81.4

0.80
0.73
1.17
0.94
1.63
1.25
1.00
0.97
0.95
0.65
1.24
1.25
1.26
1.44
1.28
1.06
1.24
1.29

(0.67,
(0.52,
(0.99,
(0.88,
(1.25,
(0.83,
(0.85,
(0.77,
(0.89,
(0.56,
(1.12,
(1.08,
(1.06,
(1.22,
(1.01,
(0.94,
(0.99,
(1.14,

0.94)
0.98)
1.37)
1.01)
2.09)
1.83)
1.17)
1.19)
1.01)
0.76)
1.37)
1.43)
1.49)
1.69)
1.59)
1.20)
1.53)
1.46)

Males
Oral cavity and pharynx
Esophagus
Stomach
Colorectal
Liver
Pancreas
Larynx
Lung/bronchus
Melanoma
Prostate
Testis
Urinary bladder
Kidney
Brain and other nervous system
Thyroid
Hodgkin's
Non-Hodgkin's
Multiple myeloma
Leukemia

0.75 (0.61,0.92)
0.64 (0.43, 0.91)
1.11 (0.90, 1.35)
0.96 (0.87, 1.05)
1.64 (1.20, 2.20)
0.99 (0.79, 1.23)
0.92 (0.72, 1.16)
0.95 (0.86, 1.01)
0.55 (0.43, 0.68)
1.02 (0.95, 1.09)
0.64 (0.46, 0.87)
1.26 (1.13, 1.40)
1.33 (1.12, 1.57)
1.13 (0.89, 1.41)
1.20 (0.84, 1.67)
1.20 (0.89, 1.59)
0.99 (0.83, 1.17)
1.46 (1.10, 1.90)
1.29 (1.10, 1.50)

Females
Oral cavity and pharynx
Esophagus
Stomach
Colorectal
Liver
Gall bladder
Pancreas
Larynx
Lung/bronchus
Melanoma
Breast
Cervix uteri
Corpus uteri
Ovary
Urinary bladder
Kidney
Brain and other nervous system
Thyroid
Hodgkin's
Non-Hodgkin's
Multiple myeloma
Leukemia

144

greater In non-Arab White women
(28%), as was cervical cancer (15%)
compared with Arab/Chaldean women.

0.92
0.91
1.23
0.93
1.48
1.27
1.01
0.94
0.93
0.76
1.04
0.85
0.94
1.03
0.99
1.02
1.35
1.57
1.23
1.13
0.96
1.23

(0.68, 1.21)
(0.48, 1.55)
(0.92, 1.60)
(0.83, 1.03)
(0.87, 2.33)
(0.75, 2.01)
(0.79, 1.27)
(0.53, 1.55)
(0.83, 1.04)
(0.61, 0.94)
(0.98, 1.10)
(0.77, 0.92)
(0.82, 0.92)
(0.87, 1.22)
(0.78, 1.24)
(0.78, 1.32)
(1.04, 1.73)
(1.29,1.88)
(0.85, 1.72)
(0.94, 1.35)
(0.64, 1.38)
(1.00, 1.49)
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This study represents an initial effort
to describe cancer patterns among Arab
Americans, a growing segment of the
population that has not been well characterized for health and disease status.
An Arab/Chaidean surname database
was developed and used to identifY
Arab/Chaldean cancer cases in the Detroit SEER database. Multiple methods
of identifYing and validating Arab/Chaldean surnames (and first names) were
employed to maximize the sensitivity
and specificity of the surname database.
In addition, our estimates of the agespecific Arab/Chaldean population
closely approximated the US Census
counts of Arab-speaking households in
the Detroit metropolitan area.
Our results bore some similarities to
the limited literature that was available
from Middle Eastern countries. Data
from only 2 Middle Eastern populationbased cancer registries are easily available. Other cancer data were utilized
from cancer registries based in large cancer treatment centers, such as Cairo
University or the American University
of Beirut. Incidence data from these
non-population-based sources may be a
reflection of the treatment expertise of
the center, rather than a true indication
of the population's cancer rates.
Lung cancer is common among
male Israeli non-Jews and men in Kuwait, Gaza, and Lebanon. 9- 11 Bladder
cancer is reported often among men in
Kuwait, Gaza, Lebanon, Egypt, and Israeli non-Jews. 9-11 Lymphoma and leukemia are frequently diagnosed in
Egypt, Lebanon. and Gaza. IO •11 Liver
cancer is a common digestive cancer in
Gaza and Kuwait.IO,11 The male Detroit
Arab-American population had increased PIRs of liver, bladder, kidney,
leukemia, and multiple myeloma.
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Proportionately fewer cancers
of testis, oral cavity, and
esophagus among Arabi
Chaldean men and fewer
cervical cancers among
women were noted.

Breast cancer is among the most
common cancer diagnoses for female Israeli non-Jews and women from Kuwait, Lebanon, Gaza, and Egypt. 9- 11
Lymphoma is frequently diagnosed in
Kuwait, Lebanon, Gaza, Egypt, and
among Israeli non-Jewish women9- 11 ;
leukemia is also common in Gaza and
Lebanon.lo,11 Brain cancer is a leading
cancer diagnosis for women in Gaza and
Lebanon, 10, II while thyroid cancer is a
malignancy common to Kuwaiti women. 9 In our study, Arab-American women had proportionally more leukemia,
brain, and thyroid cancers compared
with non-Arab Whites. A trend among
Arab/Chaldean women for more liver
and gall bladder cancers was also evident. Liver cancer appears to be fairly
common in Gaza and Kuwait,9,IO while
the migrant study conducted in Australia noted an increase in female gallbladder cancer. 3
Proportionately fewer cancers of testis, oral cavity, and esophagus among
Arab/Chaldean men and fewer cervical
cancers among women were noted. Melanoma was significantly less common
among both Arab/Chaldean men and
women. Similarly, these cancers, reported to be significantly less common for
Arab/Chaldean men and women, are
also uncommon cancers in the Middle

East.
These similarities highlight the fact
that migrant populations possess similar
cancer patterns to their home country
when first emigrating to their country
of adoption, and eventually develop

most cancers at rates comparable to
those of the native population in their
new homeland. 12 Migrants from the
Middle East arrived in Detroit in either
of 2 waves. The first wave began at the
turn of the century; the second wave began after World War II, I and continues
to the present day. Descendants of the
first wave of immigrants would be more
likely to experience cancer rates comparable to non-Arab Whites, perhaps
accounting for non-significant PIRs for
lung and colon cancer, neither of which
are among the top 5 cancer diagnoses in
Gaza and Egypt. IO On the other hand,
more recent immigrants may be experiencing cancer patterns similar to their
homeland, namely lymphoma and leukemia, liver and bladder for men; thyroid and brain cancer for women. A hereditary predisposition for these cancers
may also exist among Middle Eastern
immigrants.
Several limitations to this study deserve mention. The authors attempted
to create a surname list that was as inclusive as possible that would identify a
minimum number of non-Arab/Chaldean persons. The final list was decided
by consensus. Three reviewers, who are
very active in the Arab community, decided on the final list. Only 89.5% of
telephoned persons with a surname
from the list identified themselves as
Arab or Chaldean indicating the difficulty we encountered in creating such a
list. Many names from the Chaldean
community such Abraham, George, and
Simon are often found in a non-Arab
White community. Yet, the reviewers
felt a large proportion of the population
might be missed if these names were
simply removed. To minimize this obstacle, we developed a first name list and
required both a first and last name
match with these equivocal surnames.
Another limitation of this study was its
omission of information on time of immigration to the United States; consequently, we were unable to determine if
the Arab/Chaldean cancer cases represent first or subsequent generation immigrants.
Ethnicity & Disease, Volume 14, Winter 2004

One intriguing finding from this
study requires additional research. The
smoking rate (39%}13 among Arab
Americans in the Detroit metropolitan
area is substantially greater than national
(23%) 14 and Michigan (26%) rates. 15
Despite this, some smoking related cancers were either significantly less (25%
fewer oral cavity and pharynx, and 36%
fewer esophageal cancers) or more (26%
greater bladder) common among ArabI
Chaldeans compared with non-Arab
White men, while the lung and larynx
proportional incidence was similar for
the 2 groups. Oral cavity cancers are not
common in the Middle East,9-11 except
in Egypt where it ranks third in frequency.IO Some of the increased bladder
cancer risk could be related to the high
rates seen in parts of the Middle East.
As much as 50% of bladder cancer in
Egypt and other parts of the Middle
East is related to bilharzia (Schistosoma
haematobium}.lo Perhaps the increased
bladder PIR is due to first generation
immigrants who were exposed to this
pathogen in their home country. However, the majority of bilharzial-related
cancers in Mrica are of squamous cell
histology,12 while over 90% of the bladder cancers in our population were of
transitional cell origin.
This descriptive study was the first
to determine cancer patterns in Middle
Eastern immigrants to the United
States. Although we made multiple efforts to ensure that our surname list was
as complete as possible, we view our results as preliminary. Remembering that
proportional data are not necessarily an
accurate reflection of population-based
incidence rates is a particularly important point; yet, it is reassuring to note
that the patterns seen in our proportional incidence study were similar to
those identified in the migrant study of
Middle Easterners to Australia, which
was able to calculate incidence rates."~
Until US denominator data are available
and complete ethnicity data are present
in the medical chart, improved estimates
will be difficult to obtain. These types
145
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of data are useful for hypothesis generation, as well as following trends among
the growing Arab/Chaldean population.
Specifically, additional migration studies
should be done to improve our understanding of gene-environment interactions for cancers in this unique population.
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